|
EP0377676B1
(en)
|
1987-09-17 |
1995-05-24 |
Massachusetts Institute Of Technology |
Human erythroid-specific transcriptional enhancer
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US5484720A
(en)
|
1994-09-08 |
1996-01-16 |
Genentech, Inc. |
Methods for calcium phosphate transfection
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US5952190A
(en)
|
1996-10-04 |
1999-09-14 |
Fanconi Anemia Research Fund, Inc. |
cDNA for fanconi anemia complementation group A
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
AU770867B2
(en)
|
1999-08-13 |
2004-03-04 |
Fumie Sato |
Prostaglandin derivatives
|
|
ATE351916T1
(de)
|
1999-10-12 |
2007-02-15 |
Pasteur Institut |
Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
AU2001263006A1
(en)
|
2000-05-18 |
2001-11-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
GB0024550D0
(https=)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
EP1412493B1
(en)
|
2001-08-02 |
2011-10-05 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
|
EP1438075A4
(en)
|
2001-10-02 |
2006-04-19 |
Inst Clayton De La Rech |
METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS
|
|
WO2003088910A2
(en)
|
2002-04-15 |
2003-10-30 |
Rigel Pharmaceuticals, Inc. |
Methods of assaying for cell cycle modulators
|
|
NZ536899A
(en)
|
2002-05-02 |
2008-04-30 |
Univ Rochester |
Vectors having both isoforms of beta-hexosaminidase
|
|
WO2004094642A2
(en)
|
2003-04-24 |
2004-11-04 |
Fondazione Centro San Raffaele Del Monte Tabor |
Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
|
|
JP2007054069A
(ja)
|
2005-08-24 |
2007-03-08 |
Medizinische Hochschule Hannover |
自己不活性化レトロウイルスベクター
|
|
BE1016793A4
(fr)
|
2005-10-04 |
2007-06-05 |
Artelis |
Procede de culture de cellules et dispositif permettant sa mise en oeuvre.
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
WO2008136670A2
(en)
|
2007-05-02 |
2008-11-13 |
Erasmus University Medical Center Rotterdam |
Improved methods and means for lentiviral gene delivery
|
|
EP2152889B1
(en)
|
2007-05-29 |
2017-03-15 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
WO2009072003A2
(en)
|
2007-12-07 |
2009-06-11 |
Miltenyi Biotec Gmbh |
Sample processing system and methods
|
|
DE102008063606A1
(de)
|
2008-12-18 |
2010-06-24 |
Eufets Ag |
Ein-Vektor Tet-System und dessen Verwendung
|
|
AU2010241864B2
(en)
|
2009-04-30 |
2014-02-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
CA2763482A1
(en)
|
2009-05-27 |
2010-12-02 |
The Salk Institute For Biological Studies |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
|
US8728730B2
(en)
|
2009-09-03 |
2014-05-20 |
Genentech, Inc. |
Methods for treating, diagnosing, and monitoring rheumatoid arthritis
|
|
US20120283318A1
(en)
|
2009-10-05 |
2012-11-08 |
Mei Ya-Fang |
Replicating viral vectors for gene therapy
|
|
RU2638802C2
(ru)
|
2011-05-16 |
2017-12-15 |
Джензим Корпорейшн |
Применение антагонистов cxcr4
|
|
DK3763820T3
(da)
|
2012-02-29 |
2022-02-07 |
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh |
Retroviral transduktion ved hjælp af poloxamerer
|
|
KR102530118B1
(ko)
|
2012-07-25 |
2023-05-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
SG11201504219QA
(en)
|
2012-12-11 |
2015-06-29 |
Pall Technology Uk Ltd |
Recipient for cell cultivation
|
|
AU2013359262C1
(en)
|
2012-12-12 |
2021-05-13 |
Massachusetts Institute Of Technology |
CRISPR-Cas component systems, methods and compositions for sequence manipulation
|
|
US20160194660A1
(en)
|
2012-12-21 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Expression vectors for recombinant protein production in mammalian cells
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
CN104419683A
(zh)
*
|
2013-09-10 |
2015-03-18 |
中国科学院生物物理研究所 |
制备范可尼贫血症患者自体诱导多能干细胞的方法及其应用
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
WO2015073922A2
(en)
|
2013-11-15 |
2015-05-21 |
Northwestern University |
Inhibition of oxidative stress in atrial fibrillation
|
|
CN107405411A
(zh)
|
2014-05-01 |
2017-11-28 |
华盛顿大学 |
使用腺病毒载体的体内基因改造
|
|
EP3152221A4
(en)
|
2014-05-20 |
2018-01-24 |
Regents of the University of Minnesota |
Method for editing a genetic sequence
|
|
US11030531B2
(en)
*
|
2014-06-06 |
2021-06-08 |
Trustees Of Boston University |
DNA recombinase circuits for logical control of gene expression
|
|
GB201417042D0
(en)
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
US10350245B2
(en)
|
2015-01-21 |
2019-07-16 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
MA41506A
(fr)
|
2015-02-13 |
2017-12-19 |
Takeda Vaccines Inc |
Procédés de production de virus pour produire des vaccins
|
|
CN107635575A
(zh)
|
2015-03-10 |
2018-01-26 |
纽约市哥伦比亚大学理事会 |
重组glut1腺相关病毒载体构建体以及用于恢复glut1表达的相关方法
|
|
WO2016183593A2
(en)
|
2015-05-14 |
2016-11-17 |
The Regents Of The University Of California |
Prenatal therapy
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
DK3405215T3
(da)
|
2016-01-19 |
2022-09-19 |
Univ California |
Fremgangsmåder til behandling af danon-sygdom og andre autofagilidelser
|
|
WO2017136536A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
WO2017139576A1
(en)
|
2016-02-12 |
2017-08-17 |
Bluebird Bio, Inc. |
Vcn enhancer compositions and methods of using the same
|
|
RS67367B1
(sr)
|
2016-04-14 |
2025-11-28 |
Ferring Ventures Ltd |
Bioreaktor sa fiksiranim slojem sa pumpom/sistemom creva sa konstantnim protokom
|
|
CA3021572A1
(en)
*
|
2016-04-20 |
2017-10-26 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas |
Compositions and methods for enhanced gene expression of pklr
|
|
US20220323612A1
(en)
|
2016-06-13 |
2022-10-13 |
Bluebird Bio, Inc. |
Gene therapy of neuronal ceroid lipofuscinoses
|
|
EP3471743B1
(en)
|
2016-06-17 |
2025-08-06 |
Fred Hutchinson Cancer Center |
Strategies to assess and/or produce cell populations with predictive engraftment potential
|
|
CN110536966A
(zh)
|
2016-09-08 |
2019-12-03 |
能源环境和技术研究中心O.A.,M.P. |
用于范可尼贫血患者的基因疗法
|
|
KR20190088554A
(ko)
|
2016-12-06 |
2019-07-26 |
블루버드 바이오, 인코포레이티드. |
Ii형 점액다당류증에 대한 유전자 요법
|
|
KR20190089988A
(ko)
|
2016-12-06 |
2019-07-31 |
블루버드 바이오, 인코포레이티드. |
I형 점액다당류증에 대한 유전자 요법
|
|
US20180326022A1
(en)
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
US20200199534A1
(en)
|
2017-04-27 |
2020-06-25 |
Fred Hutchinson Cancer Research Center |
Therapeutic formulations containing cd34+ stem cells derived from negative selection
|
|
EP3697452A4
(en)
|
2017-10-16 |
2021-11-24 |
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. |
LENTIVIRAL VECTORS FOR ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFECTS
|
|
BR112020020841A2
(pt)
|
2018-04-11 |
2021-01-19 |
Fundacion Para La Investigacion Biomedica Del Hospital Infantil Universitario Nino Jesus |
Composições e métodos para transplante de célulastronco
|
|
CA3096293A1
(en)
|
2018-04-27 |
2019-10-31 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy for cns degeneration
|
|
WO2020014523A1
(en)
|
2018-07-12 |
2020-01-16 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy vectors for treatment of danon disease
|
|
KR20210046004A
(ko)
|
2018-07-30 |
2021-04-27 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
조혈 세포의 유전자 변형 방법
|
|
JP2021533831A
(ja)
|
2018-08-16 |
2021-12-09 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
ウイルスベクターのための生成方法
|
|
AU2020221842A1
(en)
|
2019-02-12 |
2021-08-12 |
Spacecraft Seven, Llc |
Gene therapy vectors for treatment of Danon Disease
|
|
CN113994008A
(zh)
|
2019-05-23 |
2022-01-28 |
太空飞船七有限责任公司 |
用于婴儿恶性骨硬化病的基因治疗载体
|
|
JP2023535121A
(ja)
|
2020-05-20 |
2023-08-16 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
操作されたパーキン及びその使用
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
BR112023001336A2
(pt)
|
2020-08-05 |
2023-02-14 |
Spacecraft Seven Llc |
Terapia gênica de csrp3 (proteína 3 rica em cisteína e glicina)
|
|
AU2021321412A1
(en)
|
2020-08-05 |
2023-04-06 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|
|
JP2023538519A
(ja)
|
2020-08-07 |
2023-09-08 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
Ａａｖベクターを使用したプラコフィリン－２（ｐｋｐ２）遺伝子治療
|
|
CA3201247A1
(en)
|
2020-12-07 |
2022-06-16 |
Gaurav Shah |
Treatment of danon disease
|
|
WO2023108029A2
(en)
|
2021-12-08 |
2023-06-15 |
Spacecraft Seven, Llc |
Junctophilin-2 (jph2) gene therapy using aav vector
|
|
WO2023108129A1
(en)
|
2021-12-10 |
2023-06-15 |
Spacecraft Seven, Llc |
Troponin c (tnnc1) gene therapy using aav vector
|
|
US20250135040A1
(en)
|
2022-02-08 |
2025-05-01 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for glut1 expression and uses thereof
|
|
KR20250012749A
(ko)
|
2022-04-22 |
2025-01-24 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 b-세포 림프종 2-관련 안타노겐 3(bag3) 유전자 요법
|